Company Profile
HANDE PHARMA is the national high-tech enterprise, which is mainly engaged in R&D anti-tumor medicine, cardiovascular and other aspects of innovative drugs. HANDE is committed to the community to provide high quality innovative medicines, key intermediates, and continue to explore new design concepts for the new drugs to help countless patients.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
(3S,4R)-4-Acetoxy-3-[(R)-1-(tert-butyldimethylsilyloxy)ethyl]azetidin-2-one |
2-Azetidinone,4-(acetyloxy)-3-[(1R)-1-[[(1,1-dimethylethyl)dimethylsilyl]oxy]ethyl]-,(3R,4R)-;2-Azetidinone,4-(acetyloxy)-3-[1-[[(1,1-dimethylethyl)dimethylsilyl]oxy]ethyl]-,[3R-[3α(R*),4β]]-;(3R,4R)-4-(Acetyloxy)-3-[(1R)-1-[[(1,1-dimethylethyl)dimethylsilyl]oxy]ethyl]-2-azetidinone;(1′R,3R,4R)-4-acetoxy-3-(1′-tert-butyldimethylsilyloxyethyl)-2-azetidinone;(3R,4R)-4-Acetoxy-3-[(R)-1-(tert-butyldimethylsilyloxy)ethyl]azetidinone;Azetidon;(3R,4R)-4-Acetoxy-3-[(R)-1-(tert-butyldimethylsiloxy)ethyl]azetidin-2-one;(3R,4R)-4-Acetoxy-3-[(R)-1-(tert-butyldimethylsilyloxy)ethyl]-2-azetidinone;(2R,3R)-3-((R)-1-(tert-Butyldimethylsiloxy)ethyl)-4-oxoazetidin-2-yl acetate;134354-63-5;91616-50-1 |
76855-69-1 | Inquiry | |
1,2,3-Triacetyl-5-deoxy-D-ribose |
β-D-Ribofuranose,5-deoxy-,1,2,3-triacetate;β-D-Ribofuranose,5-deoxy-,triacetate;1,2,3-Tri-O-acetyl-5-deoxy-β-D-ribofuranose |
62211-93-2 | Inquiry | |
1,3,5-Tri-O-benzoyl-D-ribofuranose |
α-D-Ribofuranose,1,3,5-tribenzoate;Ribofuranose,1,3,5-tribenzoate;1,3,5-Tri-O-benzoyl-α-D-ribofuranose;α-D-1,3,5-Tri-O-benzoyl-ribofuranose |
22224-41-5 | Inquiry | |
1-O-Methyl-3,5-bis-O-[(2,4-dichlorophenyl)methyl]-2-C-methyl-alpha-D-ribofuranoside |
α-D-Ribofuranoside,methyl 3,5-bis-O-[(2,4-dichlorophenyl)methyl]-2-C-methyl-;Methyl 3,5-bis-O-[(2,4-dichlorophenyl)methyl]-2-C-methyl-α-D-ribofuranoside |
443642-31-7 | Inquiry | |
1-O-Methyl-3,5-bis-O-[(2,4-dichlorophenyl)methyl]-alpha-D-erthro-pentofuranoside-2-ulose |
α-D-erythro-Pentofuranosid-2-ulose,methyl 3,5-bis-O-[(2,4-dichlorophenyl)methyl]-;Methyl 3,5-bis-O-[(2,4-dichlorophenyl)methyl]-α-D-erythro-pentofuranosid-2-ulose |
443642-30-6 | Inquiry | |
2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate |
Cytidine,2′-deoxy-2′,2′-difluoro-,3′,5′-dibenzoate;3′,5′-Di-O-benzoyl-2′-deoxy-2′,2′-difluorocytidine |
134790-39-9 | Inquiry | |
2-C-Methyl-1,3,5-tri-O-benzoyl-alpha-D-ribofuranoside |
C-2-METHYL-1,3,5-TRIBENZOYL-ALPHA-D-ARABINOFURANOSE;2-C-METHYL-1,3,5-TRI-O-BENZOYL-ALPHA-D-RIBOFURANOSE;1,3,5-Tri-O-benzoyl-2C-Methyl-α-D-ribofuranoside;2-C-methyl-1,3,5-tri-O-benzoyl-alpha-D-ribofuranos;2-C-METHYL-1,3,5-TRI-O-BENZOYL-ALPHA-D-RIBOFURANOSIDE;C-2-METHYL-1,3,5-TRIBENZOYL-A-D-ARABINOFURANOSE;2-C-Methyl-1,3,5-tri-O–benzoyl-α-D-ribofuranoside;1,3,5-Tri-O-benzoyl-2-C-methyl-a-D-ribofuranoside |
16434-48-3 | Inquiry | |
2-Deoxy-2,2-difluoro-D-erythro-pentafuranous-1-ulose-3,5-dibenzoate |
D-erythro-Pentonic acid,2-deoxy-2,2-difluoro-,γ-lactone,3,5-dibenzoate;2-Deoxy-2,2-difluoro-D-erythro-pentonic acid γ-lactone 3,5-dibenzoate;2-Deoxy-2,2-difluoro-D-erythro-pentofuranos-1-ulose-3,5-dibenzoate;1254301-18-2 |
122111-01-7 | Inquiry | |
2-Deoxy-2,2-difluoro-D-erythro-pentofuranose-3,5-dibenzoate-1-methanesulfonate |
D-ERYTHRO-PENTOFURANOSE, 2-DEOXY-2,2-DIFLUORO-, 3,5-DIBENZOATE 1-METHANESULFONATE;2-deoxy-2,2-difluoro-d-erythro-pentofuranose-3,5-dibenzoate-1-methanesulfonate;2-DEXY-2,2-DIFLUORO-3,5-O-DIBENZOYLRIBOSE MESYLATE;GeMcitabine InterMediate 8;T8, 2-Deoxy-2,2-difluoro-D-erythro-pentofuranose-3,5-dibenzoate-1-Methanesulfonate;((2R,3R)-3-(Benzoyloxy)-4,4-difluoro-5-((Methylsulfonyl)oxy)tetrahydrofuran-2-yl)Methyl benzoate;3,5-Di-O-benzoyl-2-deoxy-2,2-difluoro-1-O-methanesulfonyl-D-ribofuranoside;benzoic acid (3-benzoyloxy-4,4-difluoro-5-methylsulfonyloxy-2-oxolanyl)methyl ester |
122111-11-9 | Inquiry | |
4-(4-Fluorobenzoyl)butyric acid |
Benzenepentanoic acid,4-fluoro-δ-oxo-;4-Fluoro-δ-oxobenzenepentanoic acid;5-(4-Fluorophenyl)-5-oxopentanoic acid;4-(4-Fluorobenzoyl)butyric acid;4-(4-Fluorobenzoyl)butanoic acid |
149437-76-3 | Inquiry | |
5-(2-Bromoethyl)-2,3-dihydrobenzofuran |
Benzofuran,5-(2-bromoethyl)-2,3-dihydro-;5-(2-Bromoethyl)-2,3-dihydrobenzofuran;5-(2-Bromoethyl)-2,3-dihydrobenzo[2,3-b]furan;2,3-Dihydro-5-(2-bromoethyl)benzofuran |
127264-14-6 | Inquiry | |
5-Aza-2'-deoxycytidine |
1,3,5-Triazin-2(1H)-one,4-amino-1-(2-deoxy-β-D-erythro-pentofuranosyl)-;s-Triazin-2(1H)-one,4-amino-1-(2-deoxy-β-D-erythro-pentofuranosyl)-;4-Amino-1-(2-deoxy-β-D-erythro-pentofuranosyl)-1,3,5-triazin-2(1H)-one;5-Aza-2′-deoxycytidine;5-Azadeoxycytidine;2-Desoxy-5-azacytidine;2′-Deoxy-5-azacytidine;Decitabine;NSC 127716;DAC;Dacogen;β-Decitabine;5-Aza-2-deoxycytidine;4-Amino-1-(2-deoxy-β-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one;A 2232;NSC127716;105597-46-4;123795-43-7 |
2353-33-5 | Inquiry | |
5-O-Allyl-2,3,4-tri-O-benzyl-D-ribitol |
5-O-ALLYL-2,3,4-TRI-O-BENZYL-D-RIBITOL;2,3,4-Tris-O-(phenylmethyl)-5-O-2-propenyl-D-ribitol;5-O-Allyl-2,3,4-O-benzyl-D-ribitol;(2S,3S,4R)-5-(Allyloxy)-2,3,4-tris(benzyloxy)pentan-1-ol |
111549-97-4 | Inquiry | |
Adefovir |
Phosphonic acid,P-[[2-(6-amino-9H-purin-9-yl)ethoxy]methyl]-;Phosphonic acid,[[2-(6-amino-9H-purin-9-yl)ethoxy]methyl]-;P-[[2-(6-Amino-9H-purin-9-yl)ethoxy]methyl]phosphonic acid;9-(2-Phosphonylmethoxyethyl)adenine;PMEA;9-[2-(Phosphonomethoxy)ethyl]adenine;GS 0393;Adefovir;((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphonicacid;[[2-(6-Amino-9H-purin-9-yl)ethoxy]methyl]phosphonic acid;2-(6-Aminopurin-9-yl)ethoxymethylphosphonic acid |
106941-25-7 | Inquiry | |
Adefovir dipivoxil |
Propanoic acid,2,2-dimethyl-,1,1′-[[[[2-(6-amino-9H-purin-9-yl)ethoxy]methyl]phosphinylidene]bis(oxymethylene)] ester;Propanoic acid,2,2-dimethyl-,[[[2-(6-amino-9H-purin-9-yl)ethoxy]methyl]phosphinylidene]bis(oxymethylene) ester;GS 0840;Adefovir dipivoxil;Preveon;Hepsera;bis(POM)-PMEA;30: PN: WO2016077321 SEQID: 30 claimed sequence;[2-(6-Aminopurin-9-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate |
142340-99-6 | Inquiry | |
Dess-Martin periodinane |
Acetic acid,1,1′,1′′-(3-oxo-1λ5-1,2-benziodoxol-1(3H)-ylidyne) ester;1,2-Benziodoxol-3(1H)-one,1,1,1-tris(acetyloxy)-1,1-dihydro-;Dess-Martin periodinane;Martin's reagent;Dess-Martin reagent;Reagents,Martin's;Triacetoxyperiodinane;1,1,1-Tris(acetyloxy)-1,1-dihydro-1,2-benziodoxol-3(1H)-one;1,1,1-Triacetoxy-1,1-dihydro-1,2-benziodoxol-3(1H)-one;(1,1-Diacetoxy-3-oxo-1,2-benziodoxol-1-yl) acetate;134362-98-4;1331748-44-7 |
87413-09-0 | Inquiry | |
Entecavir |
6H-Purin-6-one,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-;6H-Purin-6-one,2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-,[1S-(1α,3α,4β)]-;2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one;BMS 200475;Entecavir;SQ 34676;Baraclude;ETV;31: PN: WO2016077321 SEQID: 31 claimed sequence |
142217-69-4 | Inquiry | |
Ethyl (3R,S)-2,2-difluoro-3-hydroxy-3-(2,2-dimethyldioxolan-4-yl)propionate |
95058-92-7 | Inquiry | ||
Ezetimibe |
2-Azetidinone,1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-,(3R,4S)-;2-Azetidinone,1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-,[3R-[3α(S*),4β]]-;(3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone;Sch 58235;Ezetimibe;(-)-Sch 58235;Zetia;Ezetrol;Ezta;Ezedoc;1-(4-Fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)azetidin-2-one;Ezentia |
163222-33-1 | Inquiry | |
Gabapentin hydrochloride |
Cyclohexaneacetic acid,1-(aminomethyl)-;1-(Aminomethyl)cyclohexaneacetic acid;Gabapentin;CI 945;Go 3450;GOE 2450;Neurontin;GOE 3450;Gabapen;Bexal;Gabamox;Generis;2-[1-(Aminomethyl)cyclohexyl]acetic acid;Conventin;Neuronyin;Neuril;Convalis;Gabarone;Gralise;Nupentin;Fanatrex;Sigma G 154;(1-Aminomethyl-cyclohexyl)-acetic acid |
60142-96-3 | Inquiry |
CONTACT INFORMATION
Sign In for Details